Actinium Pharmaceuticals, Inc. (Delaware)

Actinium Pharmaceuticals, Inc. (Delaware) financial statements

Actinium Pharmaceuticals, Inc. (Delaware)'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 90K10-K
Net income−USD 33.89M10-K
Cash and equivalentsUSD 48M10-Q
Total debtUSD 1.69MEODHD

Actinium Pharmaceuticals, Inc. (Delaware) financials on 6ix · Actinium Pharmaceuticals, Inc. (Delaware) on 6ix